Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
NAII 
Natural Alternatives International (NAII)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/20/2025: NAII (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -50.89% | Avg. Invested days 18 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/20/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 20.45M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 5425 | Beta 0.63 | 52 Weeks Range 2.57 - 6.88 | Updated Date 06/22/2025 |
52 Weeks Range 2.57 - 6.88 | Updated Date 06/22/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.39 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -6.56% | Operating Margin (TTM) 7.87% |
Management Effectiveness
Return on Assets (TTM) -3.75% | Return on Equity (TTM) -10.25% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 4800152 | Price to Sales(TTM) 0.17 |
Enterprise Value 4800152 | Price to Sales(TTM) 0.17 | ||
Enterprise Value to Revenue 0.55 | Enterprise Value to EBITDA 74.97 | Shares Outstanding 6178900 | Shares Floating 4878116 |
Shares Outstanding 6178900 | Shares Floating 4878116 | ||
Percent Insiders 21.59 | Percent Institutions 33.51 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Natural Alternatives International
Company Overview
History and Background
Natural Alternatives International (NAII) was founded in 1980. It began as a contract manufacturer of nutritional supplements. Over time, it has expanded its capabilities to include product development, testing, and global distribution, focusing on high-quality ingredients and scientific validation.
Core Business Areas
- Contract Manufacturing: NAII provides contract manufacturing services for dietary supplements, nutritional ingredients, and other health-related products. This includes formulation development, manufacturing, packaging, and labeling.
- Product Development: NAII develops its own branded products and also assists clients in developing custom formulations. The company also performs product testing and analysis.
- Global Distribution: NAII distributes its products and its clients' products globally, leveraging its supply chain expertise and international partnerships.
Leadership and Structure
Mark A. LeDoux is the Chairman of the Board and CEO. The company's organizational structure is designed to support its manufacturing, product development, and distribution operations, with dedicated teams for each area.
Top Products and Market Share
Key Offerings
- CarnoSynu00ae Beta-Alanine: NAII's flagship ingredient, CarnoSynu00ae beta-alanine, is a patented and scientifically backed ingredient used in sports nutrition and dietary supplements to enhance athletic performance. Although NAII's market share data is not publicly available, they are a major player in the beta-alanine market with a strong brand reputation. Competitors: NNB Nutrition, Alzchem Trostberg GmbH.
- SR CarnoSynu00ae Sustained Release Beta-Alanine: This is a sustained-release formulation of CarnoSyn, providing extended benefits. It caters to consumers looking for prolonged performance enhancement. Revenue data is not publicly available. Competitors: NNB Nutrition, Alzchem Trostberg GmbH.
- Custom Formulations: NAII develops and manufactures custom formulations for various clients in the dietary supplement industry. Revenue data is not publicly available. Competitors are other contract manufacturers such as Nutra Manufacturing, Captek Softgel International.
Market Dynamics
Industry Overview
The dietary supplement industry is experiencing growth driven by increasing consumer awareness of health and wellness. Key trends include personalized nutrition, sports nutrition, and immune support. The industry is highly competitive and is subject to regulatory scrutiny.
Positioning
NAII is positioned as a science-backed and high-quality contract manufacturer and ingredient supplier. Its competitive advantages include patented ingredients, scientific validation, and quality control processes.
Total Addressable Market (TAM)
The global dietary supplements market is estimated to be around $200 billion (USD) and is projected to grow in the coming years. NAII is positioned to capture a portion of this TAM through its contract manufacturing services, patented ingredients like CarnoSyn, and global distribution network.
Upturn SWOT Analysis
Strengths
- Patented ingredients (CarnoSynu00ae)
- Strong R&D capabilities
- High-quality manufacturing standards
- Global distribution network
- Science-backed products
Weaknesses
- Customer concentration risk (reliance on a few large clients)
- Limited brand recognition compared to large consumer brands
- Vulnerable to raw material price fluctuations
Opportunities
- Expanding into new international markets
- Developing new innovative ingredients
- Acquiring complementary businesses
- Capitalizing on the growing demand for personalized nutrition
- Increasing strategic partnerships
Threats
- Increased competition from other contract manufacturers
- Changing regulatory landscape
- Economic downturn affecting consumer spending
- Negative publicity or product recalls
- Patent infringement
Competitors and Market Share
Key Competitors
- NUTR
- GNC
- HLTH
Competitive Landscape
NAII competes in both the branded ingredient and contract manufacturing spaces. It differentiates itself through scientific validation and high-quality standards. However, it faces competition from larger companies with greater brand recognition and distribution reach.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: NAII's growth has been driven by the increasing popularity of its CarnoSyn ingredient and its contract manufacturing services. Historic growth figures can be extracted from company financial reports.
Future Projections: Analyst estimates for NAII's future growth can be found on financial websites. It is based on CarnoSyn sales and also the increasing demand for contract manufacturing
Recent Initiatives: Recent initiatives may include new product launches, expansion into new markets, or strategic partnerships, which can be found in press releases and investor presentations.
Summary
Natural Alternatives International demonstrates strengths in patented ingredients and quality manufacturing. However, its smaller size and customer concentration pose risks. Growth opportunities lie in international expansion and new product development, but the company must navigate competitive pressures and regulatory changes. Overall, NAII presents a mixed profile with promising prospects tempered by inherent risks within the industry.
Peer Comparison
Sources and Disclaimers
Data Sources:
- NAII's SEC filings
- NAII's investor relations website
- Financial news websites
- Industry reports
Disclaimers:
This analysis is based on publicly available information and should not be considered financial advice. Market share data is estimated and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Natural Alternatives International
Exchange NASDAQ | Headquaters Carlsbad, CA, United States | ||
IPO Launch date 1987-03-13 | Chairman of the Board & CEO Mr. Mark A. LeDoux J.D. | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 296 | Website https://www.nai-online.com |
Full time employees 296 | Website https://www.nai-online.com | ||
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, the company sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.